VIDEO

FindCenter AddIcon

There Is No Such Thing as a “Bad Drug” | Psychedcast Ft. Mark Haden

By Mark Haden — 2020

Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.

30:35 min

Psychedelic Therapy and Racial Trauma: Offering Clients a Deeper Experience of Healing

Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.

Article
Chris Lyford
2021
FindCenter AddIcon

A Brief History of Psychedelic Psychiatry

In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.

Article
Mo Costandi
2014
FindCenter AddIcon

The Movement to Decriminalize Psilocybin, Explained

The latest frontier in state and local drug reform has been the loosening of legal restrictions on psilocybin—the psychoactive compound in “magic mushrooms.”

Article
Dustin Marlan
2021
FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Article
Yasemin Saplakoglu
2019
FindCenter AddIcon

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Article
Steph Yin
2020
FindCenter AddIcon

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

Article
Whitney Joiner
2020
FindCenter AddIcon

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

Article
Zoe Cormier
2021
FindCenter AddIcon

How Should We Do Drugs Now?

While we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively?

Article
Michael Pollan
2021
FindCenter AddIcon

The New Jim Crow: Mass Incarceration in the Age of Colorblindness

Seldom does a book have the impact of Michelle Alexander’s The New Jim Crow.

Book
Michelle Alexander, Cornel West (foreword)
2020
FindCenter AddIcon

Changing Our Minds: Psychedelic Sacraments and the New Psychotherapy

Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often-confusing relationship with psychoactive substances.

Book
Don Lattin
2017
FindCenter AddIcon

EXPLORE TOPIC

Drug Policy